Oxbridge outlines T20 and T42 offerings targeting 20% and 42% annual returns while advancing tokenized data center revenue streams (NASDAQ:OXBR)May 12, 2026
Halozyme outlines ENHANZE royalties exceeding $1B in 2026 while launching a new $1B buyback (NASDAQ:HALO)May 12, 2026
Share Facebook Twitter LinkedIn Pinterest Email CEO of world's largest oil company says markets may not return to normal until 2027
Oxbridge outlines T20 and T42 offerings targeting 20% and 42% annual returns while advancing tokenized data center revenue streams (NASDAQ:OXBR)May 12, 2026
Halozyme outlines ENHANZE royalties exceeding $1B in 2026 while launching a new $1B buyback (NASDAQ:HALO)May 12, 2026
Lenz outlines sales force reaching 15,000 eye care professionals by quarter end as VIZZ adoption actions roll out (NASDAQ:LENZ)May 12, 2026
By Press Room
By Press Room
By Press Room
